Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview of innate immunity in CF lung disease, involving (i) epithelial dysfunction, (ii) pathogen sensing, (iii) leukocyte recruitment, (iv) phagocyte impairment, (v) mechanisms linking innate and adaptive immunity and (iv) the potential clinical relevance. Dissecting the complex network of innate immune regulation and associated pro-inflammatory cascades in CF lung disease may pave the way for novel immune-targeted therapies in CF and other chronic infective lung diseases.

Original publication

DOI

10.1016/j.jcf.2012.07.003

Type

Journal article

Journal

J Cyst Fibros

Publication Date

09/2012

Volume

11

Pages

363 - 382

Keywords

Adaptive Immunity, Chemokines, Cystic Fibrosis, Fibrosis, Host-Pathogen Interactions, Humans, Immune System, Immunity, Innate, Inflammation, Pseudomonas Infections, Pseudomonas aeruginosa, Respiratory System, Respiratory Tract Infections, Toll-Like Receptors